Home
About
Product
magNews
Career
Contact Us
中文
English
magNews
Corporate
Industry
Technology
Medical Updates
Corporate
Redefining New Boundaries in Delivering Patient Care
2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards
2025-01-09
Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China
2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held
2024-06-24
2022 list of China's most socially impactful startups
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device
2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth
2023-07-28
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
2023-06-17
Corporate
Embarking on an Innovation Journey with Students from Duke Kunshan University
2023-06-13
Corporate
magAssist Among Exclusive 17 Selected Enterprises in Suzhou
2023-05-29
Corporate
magAssist Once Again Named in 2023 Future Healthcare VB100 List- China Innovative Medical Devices List
2023-05-09
Corporate
magAssist Made it into the Second KPMG China Biotechnology Enterprises Top 50 List
2023-04-11
Corporate
The Chinese Start-Up Advancing Life Support Tech
2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022
2023-03-14
《
1
2
3
4
5
···
2/9
》
Tags:
Innovation,
Application,
Extra-VAD,
U.S. FDA,
Interventional Ventricular Assist Device,
Breakthrough Device,
VENTURE50,
Awards,
Healthcare,
Difference,
TOP